Advent International, agreed to acquire a majority stake in RA Chem Pharma, a vertically integrated pharmaceutical company, from Micro Labs, a multi-faceted healthcare organization. Financial terms were not disclosed. “We continue to be excited about India’s pharmaceutical landscape and investing in RA Chem Pharma will further strengthen our presence in the sector. We aim to build one of the leading API platforms in India and will leverage our financial and operational resources globally to scale RA Chem Pharma both organically and inorganically,” Shweta Jalan, Advent Managing Director and Head of India.